All Posts By

Smartkarma Daily Briefs

Daily Brief Financials: Shin Kong Financial Holding, Challenger Ltd, FWD Group Holdings, Korea Stock Exchange KOSPI 200, Slide Insurance Holdings, Indus Realty Trust Inc, Princess Private Equity Holdin, Hang Seng Index, China Vanke and more

By | Daily Briefs, Financials

In today’s briefing:

  • Shin Kong (2888 TT)/Taishin (2887 TT) – Short Timer, FX Risk, Index Flows – Time To Buy Vs Peers
  • Challenger Limited Placement: TAL Dai-Ichi Bidding Higher, Apollo Overhang Gone
  • FWD IPO: What Are We Buying?
  • KOSPI 200 Tactical Warning: OVERBOUGHT
  • Slide Holdings Insurance, Inc.(SLDE): Florida Based Insurer Looking to Ride the Tailwinds of Sector
  • Indutrade: Initiation of Coverage- How Europe’s Quiet Giant Is Diversifying to Beat Market Volatility!
  • Partners Group Private Equity — New value enhancement measures
  • Hong Kong Single Stock Options (June 09 – 13): Strong Breadth but Put Positioning Trending Higher
  • Lucror Analytics – Morning Views Asia


Shin Kong (2888 TT)/Taishin (2887 TT) – Short Timer, FX Risk, Index Flows – Time To Buy Vs Peers

By Travis Lundy

  • Shin Kong Financial Holding (2888 TT) and Taishin Financial Holding (2887 TT) are scheduled to merge in less than 6 weeks. 
  • The recent TWD strength has meant sharp losses for Shin Kong Life, but the merger agreement the FSC agreed has Taishin explicitly supporting Shin Kong Life. 
  • There are near-term flows and technical limitations which make this situation interesting again. Grab your shorts! It could be a bumpy ride!

Challenger Limited Placement: TAL Dai-Ichi Bidding Higher, Apollo Overhang Gone

By Nicholas Tan

  • AP Liberty (Apollo) is looking to raise US$170m from selling out its stake in Challenger Ltd (CGF AU) .
  • This selldown comes on the heels of a previous selldown in September 2024 ; Apollo is conducting a clean-up sale now.
  • In this note, we run the deal through our ECM framework and comment on deal dynamics.

FWD IPO: What Are We Buying?

By Alec Tseung

  • While FWD has achieved strong growth in certain key markets, its overall new business growth rate didn’t differ significantly from the peers, AIA and Prudential.
  • Compared to the peers, it offers more exposure to Thailand/Cambodia, in terms of APE and VNB mix. But, the peers still have better scale in these markets.
  • We struggle to develop the thesis unless FWD’s valuation is really attractive. It’s also not expecting to pay any dividends in the near future while both peers do.

KOSPI 200 Tactical Warning: OVERBOUGHT

By Nico Rosti

  • The KOSPI 200 INDEX has been rising > 30% since its 303-low in early April 2025: a vertical rally after Lee Jae-myung’s won the Presidential Elections in South Korea.
  • Our most extreme profit target set in our latest insight was 392. The KOSPI 200 reached 394 on June 16th. It is now ultra-overbought. 
  • Our short-term WEEKLY tactical view is the following: the index could go maybe a bit higher or it could pullback soon (more likely). Not bearish, will be a buy opportunity.

Slide Holdings Insurance, Inc.(SLDE): Florida Based Insurer Looking to Ride the Tailwinds of Sector

By IPO Boutique

  • According to our sources, the deal is well-oversubscribed with good diversification from long-only accounts.
  • Looking at the financial metrics of this company, they wrote premiums of $1.33b in 2024 which was a 52.5% increase from 2023. 
  • The success of the insurance sector as a whole including the strong performance of Ategrity Specialty Holdings (ASIC US)  last week will only further enhance the optics of this IPO.

Indutrade: Initiation of Coverage- How Europe’s Quiet Giant Is Diversifying to Beat Market Volatility!

By Baptista Research

  • Indutrade AB’s recent quarterly earnings present a nuanced picture of its current operational and financial health.
  • The company reported a 5% organic growth in order intake amidst an uncertain market environment.
  • This was primarily driven by strong demand in sectors such as pharmaceuticals, the broader process industry, and energy.

Partners Group Private Equity — New value enhancement measures

By Edison Investment Research

Partners Group Private Equity Ltd’s (PEY’s) NAV total return (TR) improved after a weaker period to 11.4% in FY24 in euro terms. It was bolstered by the successful exit of SRS Distribution (sold to Home Depot), three IPOs and solid business traction of holdings such as International Schools Partnerships (ISP) and DiversiTech. PEY’s NAV fell by 6.5% in the first four months of 2025, mostly due to fx and the de-rating of listed holdings (KinderCare Learning Companies in particular). PEY’s board made good progress in its agenda to enhance shareholder value. In FY24, it rolled out a well-structured capital allocation framework, which, on top of regular dividends, allows it to use part of PEY’s free cash flow for buybacks. The board also renegotiated PEY’s fee structure with a favourable change to the base for calculating its management and performance fee. New members joined the board and PEY scaled up its engagement with shareholders.


Hong Kong Single Stock Options (June 09 – 13): Strong Breadth but Put Positioning Trending Higher

By John Ley

  • A weekly roundup of key option and price metrics for Hong Kong single stocks.
  • Gains were broad-based again, though participation was slightly lower than the prior week.
  • We discuss the increase in Put open interest which has been trending higher over the past month.

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: China Vanke, Tata Motors
  • US Treasury yields rose 3-5 bps across the curve on Friday, as the surge in oil prices amid the Iran-Israel conflict stoked renewed inflation concerns. The yield on the 2Y UST rose 4 bps to 3.95%, while the yield on the 10Y UST climbed 4 bps to 4.40%.
  • Equities retreated, with tech- and travel-related stocks declining, while energy producers and defence stocks rose. The S&P 500 fell 1.1% to 5,977, while the Nasdaq Composite declined 1.3% to 19,407.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Mayne Pharma, Biocon Ltd, Bayzed Health Group, Caris Life Sciences, TransThera Sciences (Nanjing), Vivos Therapeutics , Lexaria Bioscience , Q & M Dental Group (Singapore) and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Mayne Pharma: No Precedence for a Deal Termination
  • Biocon Ltd QIP – Well Flagged US$522m QIP; Largely Towards Clearing Debt
  • Bayzed Health Group IPO: Shows Flare; Still a Tough Road Ahead; Can Avoid The Issue
  • Caris Life Sciences, Inc. (CAI): Price Bumped Higher, Intersection of Cancer and AI in High Demand
  • TransThera Sciences (Nanjing) IPO: Uniqueness of Lead Candidate Provides Comfort for Long-Term
  • Vivos Therapeutics, Inc: SCN Acquisition Closed; Key Step in Strategic Pivot
  • LEXX: GLP-1-H25-5 Study Complete
  • STI Banks Lead Weekly Buyback Consideration Tally


Mayne Pharma: No Precedence for a Deal Termination

By Nicholas Tan

  • Cosette signed a binding agreement to acquire Mayne Pharma (MYX AU)  for $7.40 per share.
  • Cosette predictably got cold feet and is attempting to terminate the deal, invoking the deal’s material adverse clause.
  • Moreover, Cosette has repeatedly failed to quantify its allegations. The extant stock price implies a less than 30% chance of deal closure in spite of having zero precedence for support.

Biocon Ltd QIP – Well Flagged US$522m QIP; Largely Towards Clearing Debt

By Akshat Shah

  • Biocon Ltd (BIOS IN) Biocon Ltd is looking to raise up to US$522m in its qualified institutional placement (QIP).
  • The deal is well flagged, having gone through rounds of board/shareholder approvals. The QIP has also been covered by domestic media reports.
  • In this note, we run the deal through our ECM framework and comment on deal dynamics.

Bayzed Health Group IPO: Shows Flare; Still a Tough Road Ahead; Can Avoid The Issue

By Tina Banerjee

  • Bayzed Health Group (BHG HK) launched its Hongkong IPO aiming to raise up to HK$ 900 million. The company plans to sell 133 million shares at HK$4.22–6.75 per share.
  • The company plans to utilize the IPO proceeds to continuously strengthening the full-cycle oncology healthcare services primarily through purchasing medical equipment and recruiting medical professionals.
  • Bayzed Health is an oncology healthcare group which posted revenue of RMB 1,189 million in 2024, up by 11% YoY. Gross margins improve; net losses narrow too.

Caris Life Sciences, Inc. (CAI): Price Bumped Higher, Intersection of Cancer and AI in High Demand

By IPO Boutique

  • Caris Life Sciences increased the price range on its IPO on Monday ahead of a Wednesday scheduled debut.
  • According to our sources, the deal is multiple-times oversubscribed with a mix of new and existing investors. There are multiple mutual-fund anchor orders in the book.
  • Given how important this company’s technology is to the cancer arena and the revenue growth  that is “ramping” into the IPO, we like the risk-reward profile of this deal.

TransThera Sciences (Nanjing) IPO: Uniqueness of Lead Candidate Provides Comfort for Long-Term

By Tina Banerjee

  • TransThera Sciences, a clinical-stage biopharma, filed to list on HK. The company aims to raise HK$200M by offering 15M shares. The offer price is set at HK$13.15 ($1.7) per share.
  • The IPO opened on June 13 and closes on June 18. Allocations are expected on June 20, while trading is anticipated to commence on June 23.
  • The company intends to use the IPO proceeds to fund the research and development of core product candidate, Tinengotinib for various types of solid tumors.

Vivos Therapeutics, Inc: SCN Acquisition Closed; Key Step in Strategic Pivot

By Water Tower Research

  • SCN acquisition closed, marking a pivotal milestone in the new marketing model.
  • Vivos completed the acquisition of the Sleep Center of Nevada (SCN), paying $6.0 million in cash and $1.5 million in stock upfront.
  • SCN remains eligible for an additional $1.5 million contingent stock payment if a financial milestone is achieved. 

LEXX: GLP-1-H25-5 Study Complete

By Zacks Small Cap Research

  • Zacks Small-Cap Research Note for Lexaria Bioscience Corp. (LEXX)

STI Banks Lead Weekly Buyback Consideration Tally

By Geoff Howie

  • Institutions were net sellers of Singapore stocks with a net outflow of S$80 million from June 6-12.
  • DBS Group Holdings, United Overseas Bank, and Oversea-Chinese Banking Corporation led share buybacks totaling S$66.8 million.
  • Q & M Dental Group’s CEO increased his stake to 54.92% amid ongoing share buyback program since May 8.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Mayne Pharma, Adriatic Metals PLC, Santos Ltd, PointsBet Holdings , Challenger Ltd, Jupiter Mines, Readcloud Ltd and more

By | Australia, Daily Briefs

In today’s briefing:

  • Mayne Pharma: No Precedence for a Deal Termination
  • Adriatic Metals (ADT AU)/Dundee Metals (DPM CN): A Burgeoning Balkan Play
  • Santos (STO AU): XRG’s Non-Binding Offer Faces an FIRB Challenge
  • PointsBet (PBH AU) [Further] Backs MIXI’s Offer, Rejects Betr’s
  • Challenger Limited Placement: TAL Dai-Ichi Bidding Higher, Apollo Overhang Gone
  • Jupiter Mines Takeover Potential, Wanda Hotel Special Dividend, and OCI Methanol Sale Near Completion
  • Readcloud Ltd – Delivering profitable growth


Mayne Pharma: No Precedence for a Deal Termination

By Nicholas Tan

  • Cosette signed a binding agreement to acquire Mayne Pharma (MYX AU)  for $7.40 per share.
  • Cosette predictably got cold feet and is attempting to terminate the deal, invoking the deal’s material adverse clause.
  • Moreover, Cosette has repeatedly failed to quantify its allegations. The extant stock price implies a less than 30% chance of deal closure in spite of having zero precedence for support.

Adriatic Metals (ADT AU)/Dundee Metals (DPM CN): A Burgeoning Balkan Play

By David Blennerhassett

  • Dual-Listed Adriatic Metals PLC (ADT AU) has announced a cash/scrip Offer from Dundee Precious Metals (DPM CN) with an implied Offer price of A$5.56/share, a 47.8% premium to undisturbed.
  • Dundee is offering 0.1590 new Dundee shares per ADT share, plus 93 pence in cash. Roughly a 35:65 cash/scrip split for the Aussie listed line. 
  • Adriatic is incorporated in the UK so the Offer is being done by a UK Scheme. Irrevocables tally 37.23%. Clean deal.

Santos (STO AU): XRG’s Non-Binding Offer Faces an FIRB Challenge

By Arun George

  • Santos Ltd (STO AU) has disclosed a “final” non-binding proposal from the XRG consortium at US$5.76 (A$8.89), a 27.7% premium to the undisturbed price of A$6.96 (13 June).
  • The offer is subject to several regulatory approvals. FIRB approval is the primary risk due to a foreign government-controlled entity controlling critical domestic infrastructure assets.
  • The offer is attractive compared to peer multiples and historical trading ranges. Retail has a mixed view on the offer, which should not be an issue for the vote.  

PointsBet (PBH AU) [Further] Backs MIXI’s Offer, Rejects Betr’s

By David Blennerhassett

  • On the 3rd June, MIXI bumped Scheme terms to A$1.20/share; and should the Scheme fail, MIXI was “willing to consider” an off-market takeover at A$1.20/share with a 50.1% acceptance hurdle.
  • PointsBet (PBH AU) has now entered a bid implementation deed with MIXI on the off-market Offer, conditional on the Scheme failing; which it will given BETR (BBT AU)‘s 19.9% stake.
  • And on Betr? PBH has rejected its Offer, questioning the computation of the synergies, and calling the bid materially below MIXI’s.

Challenger Limited Placement: TAL Dai-Ichi Bidding Higher, Apollo Overhang Gone

By Nicholas Tan

  • AP Liberty (Apollo) is looking to raise US$170m from selling out its stake in Challenger Ltd (CGF AU) .
  • This selldown comes on the heels of a previous selldown in September 2024 ; Apollo is conducting a clean-up sale now.
  • In this note, we run the deal through our ECM framework and comment on deal dynamics.

Jupiter Mines Takeover Potential, Wanda Hotel Special Dividend, and OCI Methanol Sale Near Completion

By Special Situation Investments

  • Jupiter Mines (JMS:AX) potential takeover: JV sale valued Tshipi mine at A$0.315/share, 60% above current trading levels.
  • OCI N.V. (OCI:AS) nearing methanol business sale completion: US$1.2bn cash, 9.9 million MEOX shares, €8/share net cash position.
  • Mayne Pharma (MYX:AX) merger dispute: Cosette issued termination notice, MYX denies allegations, court hearing scheduled for September 9.

Readcloud Ltd – Delivering profitable growth

By Research as a Service (RaaS)

  • ReadCloud Limited (ASX:RCL) services the education sector through the provision of digital learning content, proprietary interactive technology, and support for students and educators.
  • The company has released its H1 FY25 interim result (September year-end), illustrating a continuation of strong momentum in the core schools-focussed businesses.
  • Group sales and fee revenue grew 13% to $9.2m, underlying EBITDA strengthened 73% to $1.8m, with strong cash conversion delivering operating cash flow of $1.9m for the half, leaving the company with $3.5m cash and no debt at period end.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Live Nation Entertainment, Inc, Foshan Haitian Flavouring & Food Company, Dongwon Industries, PointsBet Holdings , Yamada Denki, Market Vectors Vietnam ETF, Hennes & Mauritz AB, Eternal Beauty Holdings Limited, TSE Tokyo Price Index TOPIX and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Select Sector Indices and S&P Equal Weight Rebalance: US$12.7bn Round-Trip Trade Post Capping
  • Foshan Haitian Flavouring & Food Company Hong Kong IPO Preview
  • Three Key Angles when Hunting Div Arb Setups in the Korean Market
  • PointsBet (PBH AU) [Further] Backs MIXI’s Offer, Rejects Betr’s
  • When Giants Clash: Yamada (9831) Vs. Nitori (9843)
  • Foshan Haitian HK Offer: Pantry Staples at Pricey Valuations. Key Facts, Financials & More
  • Postcard from Hanoi | Xin Chào Việt Nam
  • H&M (Hennes & Mauritz AB): Initiation of Coverage- The High-Stakes Bet on Value
  • Pre-IPO Eternal Beauty Holdings (PHIP Updates) – The Outlook Has Changed
  • Many Companies Are in Stage of Setting Caps to Ensure that Cash on Hand Grows No More than Necessary


Select Sector Indices and S&P Equal Weight Rebalance: US$12.7bn Round-Trip Trade Post Capping

By Brian Freitas


Foshan Haitian Flavouring & Food Company Hong Kong IPO Preview

By Douglas Kim

  • Foshan Haitian Flavouring & Food Company is the largest listed condiments producer in mainland China which is seeking to raise up to HK$9.56 billion (US$1.22 billion) in Hong Kong listing.
  • It is offering 263.2 million shares at HK$35 to HK$36.30 each. The final offer price is expected to be announced on 17 June. 
  • Foshan Haitian Flavouring & Food is the largest condiments company in China with strong brand power with loyal customers.

Three Key Angles when Hunting Div Arb Setups in the Korean Market

By Sanghyun Park

  • Is the SSF base price automatically adjusted on ex-div day? No — Korea doesn’t mechanically adjust cash or futures base prices on ex-div, keeping dividend arb opportunities alive.
  • Could front-month futures flip into contango near ex-div? It’s rare but possible, especially with KRX’s aggressive SSF reshuffles and KOSDAQ Global additions shaking up liquidity and basis volatility.
  • Arb plays may arise from Korea’s new 27.5% div tax on payouts over 35%. Ex-div timing and payout uncertainty may create opportunities for dividend arb setups.

PointsBet (PBH AU) [Further] Backs MIXI’s Offer, Rejects Betr’s

By David Blennerhassett

  • On the 3rd June, MIXI bumped Scheme terms to A$1.20/share; and should the Scheme fail, MIXI was “willing to consider” an off-market takeover at A$1.20/share with a 50.1% acceptance hurdle.
  • PointsBet (PBH AU) has now entered a bid implementation deed with MIXI on the off-market Offer, conditional on the Scheme failing; which it will given BETR (BBT AU)‘s 19.9% stake.
  • And on Betr? PBH has rejected its Offer, questioning the computation of the synergies, and calling the bid materially below MIXI’s.

When Giants Clash: Yamada (9831) Vs. Nitori (9843)

By Michael Allen

  • Yamada, Japan’s leading home appliance retailer, trade at a PER of less than 9x. Nitori, the leading furniture retailer trades at about 17x.
  • Both companies, having saturated their core market, are diversifying into the other’s territory.
  • Key Takeaway: Nitori is diversifying into a business with inherently lower margins, while Yamada moves into one with inherently higher margins.

Foshan Haitian HK Offer: Pantry Staples at Pricey Valuations. Key Facts, Financials & More

By Devi Subhakesan

  • Foshan Haitian, already listed in Shanghai, is offering 263.2 million shares in Hong Kong to raise up to HKD9.56 billion (USD1.22 billion); Final offer price will be set by today.
  • HK offer price is pitched at an appealing 19%–22% discount to its A-share close, however valuations are pricing in growth expectations that may not align with the underlying business dynamics.
  • Foshan Haitian operates in the condiments and sauces segment—a mature, saturated and competitive market with limited room for meaningful margin or volume expansion.

Postcard from Hanoi | Xin Chào Việt Nam

By Pranav Bhavsar

  • In this Postcard Edition, we detour and go international—to the streets, shops, and supermarkets of Vietnam. Choosing Vietnam as a country to explore and begin building our Asian Coverage.
  • Despite strong manufacturing fundamentals, capital markets remain narrow, with limited institutional participation and underrepresentation of export-led sectors.
  • Vietnam is on our watchlist for its evolving opportunity set, and we will continue tracking IPO activity, MSCI inclusion efforts, and policy reforms.

H&M (Hennes & Mauritz AB): Initiation of Coverage- The High-Stakes Bet on Value

By Baptista Research

  • Hennes & Mauritz AB (H&M Group) presented its first quarter results for 2025, reflecting a mixed performance amid efforts to strategize for long-term profitable growth.
  • Sales in Swedish krona grew by 3%, while local currency sales increased by 2%.
  • The company experienced strong sales performance in regions like Western, Southern, and Eastern Europe, particularly in Germany and Poland, but sales were weaker in Northern Europe, including the Nordics and the U.K., as well as in the U.S. Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Pre-IPO Eternal Beauty Holdings (PHIP Updates) – The Outlook Has Changed

By Xinyao (Criss) Wang

  • Given that leading luxury groups are inclined to abandon agency and “get involved directly” in the beauty/fragrance category, such trend implies the risk of losing key suppliers in the future
  • Although there’re “reusable aspects” in management, expenses spent on brand channel are big, which makes it impossible for profits to benefit from “scale effect”.So, low profit margin is the norm.
  • Considering the risk of economic recession/sluggish consumption, Eternal Beauty’s net profit may experience negative growth in FY2025. It would gradually recover in FY2026-2027. Valuation could be lower than peers.

Many Companies Are in Stage of Setting Caps to Ensure that Cash on Hand Grows No More than Necessary

By Aki Matsumoto

  • Improvements in OP margin and Sales/Total Assets have been slow to improve ROE. More companies are including DOE in their dividend policy against the backdrop of increasing cash on hand.
  • With costs expected to increase amid rising prices, sales and gross margins need to be raised, and therefore the component costs of investment and high-margin operations need to be raised.
  • Restructuring the business portfolio later to determine cash allocation will not result in effective investment and must result in limited improvement in profit margins on sales.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thailand: Delta Electronics Thailand and more

By | Daily Briefs, Thailand

In today’s briefing:

  • SET50 Index Rebalance: Four Changes in Two Weeks; DELTA Capping Too


SET50 Index Rebalance: Four Changes in Two Weeks; DELTA Capping Too

By Brian Freitas


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Telcoware, Asia Holdings, Dongwon Industries, Korea Stock Exchange KOSPI 200 and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Telcoware & Shinsung Tongsang Tender Offers: Minority Shareholders Demand Higher Tender Offer Prices
  • [Quiddity Index Jun25] KOSPI 200 Leaderboard for Dec25 Rebal: 4 In/Out But Too Early to Bet
  • Three Key Angles when Hunting Div Arb Setups in the Korean Market
  • KOSPI 200 Tactical Warning: OVERBOUGHT


Telcoware & Shinsung Tongsang Tender Offers: Minority Shareholders Demand Higher Tender Offer Prices

By Douglas Kim

  • Telcoware (078000 KS) and Shinsung Tongsang (005390 KS) are two recent tender offers in Korea where the minority shareholders are demanding higher tender offer prices.
  • The actual subscription rate of the Telcoware tender offer was only 10.44%, far below the 25.24% targeted by the CEO Keum Han-Tae.
  • The Shinsung Tongsang owner family may acquire an additional 7–10% stake via this tender offer, though it remains unclear if they can secure full 95% ownership at this stage.

[Quiddity Index Jun25] KOSPI 200 Leaderboard for Dec25 Rebal: 4 In/Out But Too Early to Bet

By Travis Lundy

  • KOSPI 200 is a Korean blue-chip index that tracks the 200 largest and most-liquid names listed in the KOSPI section of the Korea Exchange (KRX).
  • In this insight, we take a look at the names leading the race to become ADDs and DELs during the next semiannual review in December 2025.
  • We expect up to 4 ADDs and 4 DELs in the KOSPI 200 index during the December 2025 index rebal event based on the latest available data.

Three Key Angles when Hunting Div Arb Setups in the Korean Market

By Sanghyun Park

  • Is the SSF base price automatically adjusted on ex-div day? No — Korea doesn’t mechanically adjust cash or futures base prices on ex-div, keeping dividend arb opportunities alive.
  • Could front-month futures flip into contango near ex-div? It’s rare but possible, especially with KRX’s aggressive SSF reshuffles and KOSDAQ Global additions shaking up liquidity and basis volatility.
  • Arb plays may arise from Korea’s new 27.5% div tax on payouts over 35%. Ex-div timing and payout uncertainty may create opportunities for dividend arb setups.

KOSPI 200 Tactical Warning: OVERBOUGHT

By Nico Rosti

  • The KOSPI 200 INDEX has been rising > 30% since its 303-low in early April 2025: a vertical rally after Lee Jae-myung’s won the Presidential Elections in South Korea.
  • Our most extreme profit target set in our latest insight was 392. The KOSPI 200 reached 394 on June 16th. It is now ultra-overbought. 
  • Our short-term WEEKLY tactical view is the following: the index could go maybe a bit higher or it could pullback soon (more likely). Not bearish, will be a buy opportunity.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: SGX Rubber Future TSR20, OUE REIT, Q & M Dental Group (Singapore) and more

By | Daily Briefs, Singapore

In today’s briefing:

  • Helixtap China Report: China Rubber Market Faces Continued Headwinds
  • REIT Watch – Diversified S-REITs’ operating performance remain resilient amid market uncertainties
  • STI Banks Lead Weekly Buyback Consideration Tally


Helixtap China Report: China Rubber Market Faces Continued Headwinds

By Arusha Das

  • Physical-to-INE spreads indicate sluggish near-term demand
  • Rising availability and tepid downstream suggests prices may remain under pressure 
  • April’s import and export data highlights the caution in the market  

REIT Watch – Diversified S-REITs’ operating performance remain resilient amid market uncertainties

By Geoff Howie

  • Suntec REIT’s 1Q 2025 gross revenue increased 3.4% y-o-y to S$113.5 million, with DPU up 3.4% y-o-y.
  • CICT’s 1Q 2025 gross revenue was S$395.3 million, up 1.1% y-o-y, with NPI increasing 1.4% y-o-y.
  • Suntec REIT completed S$730 million refinancing, resulting in annual interest savings of approximately S$1.8 million.

STI Banks Lead Weekly Buyback Consideration Tally

By Geoff Howie

  • Institutions were net sellers of Singapore stocks with a net outflow of S$80 million from June 6-12.
  • DBS Group Holdings, United Overseas Bank, and Oversea-Chinese Banking Corporation led share buybacks totaling S$66.8 million.
  • Q & M Dental Group’s CEO increased his stake to 54.92% amid ongoing share buyback program since May 8.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Live Nation Entertainment, Inc, Ciena Corp, Slide Insurance Holdings, Intel Corp, Caris Life Sciences, Vivos Therapeutics , GameStop, Indus Realty Trust Inc, Keysight Technologies In, Base Oil and more

By | Daily Briefs, United States

In today’s briefing:

  • Select Sector Indices and S&P Equal Weight Rebalance: US$12.7bn Round-Trip Trade Post Capping
  • Ciena Corporation Reveals Pluggable Optics Power—Is 800G the Next Big Telecom Breakthrough?
  • Slide Holdings Insurance, Inc.(SLDE): Florida Based Insurer Looking to Ride the Tailwinds of Sector
  • Intel Is Shrinking (Headcount), Declining (Market Share), but Weakness Can Be a Strength
  • Caris Life Sciences, Inc. (CAI): Price Bumped Higher, Intersection of Cancer and AI in High Demand
  • Vivos Therapeutics, Inc: SCN Acquisition Closed; Key Step in Strategic Pivot
  • GameStop’s Crypto Gamble & AI Facelift: A Meme Stock On Life Support?
  • Indutrade: Initiation of Coverage- How Europe’s Quiet Giant Is Diversifying to Beat Market Volatility!
  • Keysight Technologies Taps into 6G & Open RAN—Is This the Future of Wireless Dominance?
  • Oil Prices Rise as Israel Attacks Iran’s Nuclear Facilities – What We Do


Select Sector Indices and S&P Equal Weight Rebalance: US$12.7bn Round-Trip Trade Post Capping

By Brian Freitas


Ciena Corporation Reveals Pluggable Optics Power—Is 800G the Next Big Telecom Breakthrough?

By Baptista Research

  • Ciena Corporation’s financial results for the fiscal second quarter of 2025 reflect robust performance and strategic positioning within the dynamic networking and telecommunications industry.
  • The company reported revenue of $1.13 billion, marking alignment with the high end of their guidance, an indicator of successful strategy execution and market demand.
  • This strong revenue performance is underscored by substantial growth in cloud provider revenue, which represented 38% of total revenue and grew by 85% year-over-year to over $400 million in the quarter.

Slide Holdings Insurance, Inc.(SLDE): Florida Based Insurer Looking to Ride the Tailwinds of Sector

By IPO Boutique

  • According to our sources, the deal is well-oversubscribed with good diversification from long-only accounts.
  • Looking at the financial metrics of this company, they wrote premiums of $1.33b in 2024 which was a 52.5% increase from 2023. 
  • The success of the insurance sector as a whole including the strong performance of Ategrity Specialty Holdings (ASIC US)  last week will only further enhance the optics of this IPO.

Intel Is Shrinking (Headcount), Declining (Market Share), but Weakness Can Be a Strength

By Nicolas Baratte

  • Intel layoffs now extending to production in US, Israel. Intel’s revenue/employee is half that of AMD, TSMC. An AMD or TSMC employee generates 2x more revenue than an Intel employee. 
  • Intel shareloss in PC, Server continues. Over the past 4 years Intel lost 6 percentage points PC market share (down to 76%), 13 percentage points in server (down to 73%).   
  • Intel is now without an AI / GPU roadmap. It looks bad but the twist is it helps Intel requalify with Nvidia DGX, replacing AMD. Weakness breeds strength.   

Caris Life Sciences, Inc. (CAI): Price Bumped Higher, Intersection of Cancer and AI in High Demand

By IPO Boutique

  • Caris Life Sciences increased the price range on its IPO on Monday ahead of a Wednesday scheduled debut.
  • According to our sources, the deal is multiple-times oversubscribed with a mix of new and existing investors. There are multiple mutual-fund anchor orders in the book.
  • Given how important this company’s technology is to the cancer arena and the revenue growth  that is “ramping” into the IPO, we like the risk-reward profile of this deal.

Vivos Therapeutics, Inc: SCN Acquisition Closed; Key Step in Strategic Pivot

By Water Tower Research

  • SCN acquisition closed, marking a pivotal milestone in the new marketing model.
  • Vivos completed the acquisition of the Sleep Center of Nevada (SCN), paying $6.0 million in cash and $1.5 million in stock upfront.
  • SCN remains eligible for an additional $1.5 million contingent stock payment if a financial milestone is achieved. 

GameStop’s Crypto Gamble & AI Facelift: A Meme Stock On Life Support?

By Baptista Research

  • GameStop, the once-mighty video game retailer turned meme stock sensation, is back in the headlines—but not for reasons that inspire confidence.
  • The company recently announced a $1.75 billion offering of 0% convertible senior notes due 2032, triggering a nearly 20% plunge in its share price.
  • Investors were spooked not only by the prospect of future dilution but also by GameStop’s new strategy: pouring hundreds of millions into Bitcoin, mimicking the controversial playbook of MicroStrategy.

Indutrade: Initiation of Coverage- How Europe’s Quiet Giant Is Diversifying to Beat Market Volatility!

By Baptista Research

  • Indutrade AB’s recent quarterly earnings present a nuanced picture of its current operational and financial health.
  • The company reported a 5% organic growth in order intake amidst an uncertain market environment.
  • This was primarily driven by strong demand in sectors such as pharmaceuticals, the broader process industry, and energy.

Keysight Technologies Taps into 6G & Open RAN—Is This the Future of Wireless Dominance?

By Baptista Research

  • Keysight Technologies reported its fiscal second quarter 2025 earnings, highlighting several key aspects that investors may find noteworthy.
  • The company delivered a robust performance, with revenues at $1.3 billion and earnings per share of $1.70, both exceeding the high-end of guidance.
  • This performance marks continued revenue growth, driven by strong demand in the Communications Solutions Group (CSG) and a return to growth in the Electronics Industrial Solutions Group (EISG).

Oil Prices Rise as Israel Attacks Iran’s Nuclear Facilities – What We Do

By The Commodity Report

  • YTD our absolute return strategy is up 12,0% Oil Prices Rise as Israel Attacks Iran’s Nuclear Facilities – What We Do Friday was marked by panic buying safe haven assets.
  • Gold and Crude went up, risk assets went down. We’re now in a time of mass geopolitical uncertainty and related volatility.
  • Therefore we think it is important to keep a cool head in such situations and don’t let headlines and breaking news change investment behavior.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Nakano Refrigerators, Ascentech KK, Carta Holdings, Inc., Yamada Denki, TSE Tokyo Price Index TOPIX, Timee Inc and more

By | Daily Briefs, Japan

In today’s briefing:

  • Nakano Refrigerators (6411 JP): Marunouchi Capital’s JPY7,900 Tender Offer
  • Ascentech (3565 JP): Orix (8591 JP)’s JPY1,680 Tender Offer
  • [Japan M&A] NTT Docomo Buys Out Carta Holdings (3688) Minorities – Done Deal
  • When Giants Clash: Yamada (9831) Vs. Nitori (9843)
  • Carta Holdings (3688 JP): NTT DoCoMo’s JPY2,100 Preconditional Tender Offer Is a Done Deal
  • Many Companies Are in Stage of Setting Caps to Ensure that Cash on Hand Grows No More than Necessary
  • Timee 2Q Results: Revenue Decline Is Only Temporary


Nakano Refrigerators (6411 JP): Marunouchi Capital’s JPY7,900 Tender Offer

By Arun George

  • Nakano Refrigerators (6411 JP) has recommended a tender offer from Marunouchi Capital at JPY7,900, a 35.0% premium to the last close price.
  • The offer is attractive as it represents an all-time high and is above the midpoint of the IFA DCF valuation range.
  • An attractive offer and irrevocables (33.19% ownership ratio) pave the way for deal completion. The tender runs from 17 June to 29 July.

Ascentech (3565 JP): Orix (8591 JP)’s JPY1,680 Tender Offer

By Arun George

  • Ascentech KK (3565 JP) has recommended a tender offer from Orix Corp (8591 JP) at JPY1,680, a 14.6% premium to the last close price.
  • Despite the lack of an auction, the offer is reasonable compared to historical trading ranges and aligns with the midpoint of the IFA DCF valuation range.
  • Minimum tendering is set at a 66.67% ownership ratio, with irrevocables representing a 27.81% ownership ratio. Management’s significant stakes aid in deal completion.

[Japan M&A] NTT Docomo Buys Out Carta Holdings (3688) Minorities – Done Deal

By Travis Lundy

  • On 16 June 2025, NTT (Nippon Telegraph & Telephone) (9432 JP) sub NTT Docomo and Dentsu Inc (4324 JP) announced Docomo would buy out minorities in Dentsu sub Carta Holdings.
  • It’s an OK price, not a great price. But while they are not calculated by advisors, at least the Target Board talks about the value of synergies to minorities.
  • The price is light, but the combined irrevocables and large individual shareholders not brought over the wall get this over the line.

When Giants Clash: Yamada (9831) Vs. Nitori (9843)

By Michael Allen

  • Yamada, Japan’s leading home appliance retailer, trade at a PER of less than 9x. Nitori, the leading furniture retailer trades at about 17x.
  • Both companies, having saturated their core market, are diversifying into the other’s territory.
  • Key Takeaway: Nitori is diversifying into a business with inherently lower margins, while Yamada moves into one with inherently higher margins.

Carta Holdings (3688 JP): NTT DoCoMo’s JPY2,100 Preconditional Tender Offer Is a Done Deal

By Arun George

  • Carta Holdings, Inc. (3688 JP) has recommended a preconditional tender offer from NTT (Nippon Telegraph & Telephone) (9432 JP) at JPY2,100, a 37.2% premium to the last close price.
  • The offer is preconditional on several regulatory approvals, expected to commence in late August, and aligns with the midpoint of the IFA DCF valuation range.
  • Due to irrevocables from the controlling shareholder and key management, the required minority tendering rate is 11.2%. This low rate points to a done deal. 

Many Companies Are in Stage of Setting Caps to Ensure that Cash on Hand Grows No More than Necessary

By Aki Matsumoto

  • Improvements in OP margin and Sales/Total Assets have been slow to improve ROE. More companies are including DOE in their dividend policy against the backdrop of increasing cash on hand.
  • With costs expected to increase amid rising prices, sales and gross margins need to be raised, and therefore the component costs of investment and high-margin operations need to be raised.
  • Restructuring the business portfolio later to determine cash allocation will not result in effective investment and must result in limited improvement in profit margins on sales.

Timee 2Q Results: Revenue Decline Is Only Temporary

By Shifara Samsudeen, FCMA, CGMA

  • Timee Inc (215A JP)  reported 2QFY10/2025 results on Thursday, 12th June. Revenues fell below consensus while OP beat consensus by a huge margin despite 2Q being a seasonally weak quarter.
  • Top line was hit by unauthorized use of services which forced Timee to strengthen counter measures. End of client fiscal year in food industry also contributed to the decline.
  • There are signs of recovery and the company’s share price moved up 7% on Friday on the back of strengthening profitability.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Biocon Ltd, Tata Motors and more

By | Daily Briefs, India

In today’s briefing:

  • Biocon Ltd QIP – Well Flagged US$522m QIP; Largely Towards Clearing Debt
  • Short Tata Motors – JLR Investor Day – All About Tariffs, China & BEV. Guidance Slashed for FY26.


Biocon Ltd QIP – Well Flagged US$522m QIP; Largely Towards Clearing Debt

By Akshat Shah

  • Biocon Ltd (BIOS IN) Biocon Ltd is looking to raise up to US$522m in its qualified institutional placement (QIP).
  • The deal is well flagged, having gone through rounds of board/shareholder approvals. The QIP has also been covered by domestic media reports.
  • In this note, we run the deal through our ECM framework and comment on deal dynamics.

Short Tata Motors – JLR Investor Day – All About Tariffs, China & BEV. Guidance Slashed for FY26.

By Sreemant Dudhoria,CFA

  • Tata Motors (TTMT IN)subsidiary Jaguar Land Rover’s volumes, revenue, EBIT margins and FCF all plateaued in FY25.
  • US Tariffs & China Slowdown Undermine FY26 Outlook: The tariffs on UK car imports and collapsing China JV performance together threaten JLR’s two most profitable regions.
  • Company expects JLR EBIT margin to crash to the 5–7% range (vs 8.5% in FY25) and FCF to fall to zero vs GBP 1.5 billion in FY25.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars